Free Trial

Vertex Pharmaceuticals (VRTX) Competitors

Vertex Pharmaceuticals logo
$454.64 -2.40 (-0.52%)
Closing price 07/3/2025 03:51 PM Eastern
Extended Trading
$454.64 0.00 (0.00%)
As of 07/3/2025 04:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

VRTX vs. AMZN, AXSM, CRSP, GOOG, ISRG, MRNA, RGEN, ABBV, LLY, and PFE

Should you be buying Vertex Pharmaceuticals stock or one of its competitors? The main competitors of Vertex Pharmaceuticals include Amazon.com (AMZN), Axsome Therapeutics (AXSM), CRISPR Therapeutics (CRSP), Alphabet (GOOG), Intuitive Surgical (ISRG), Moderna (MRNA), Repligen (RGEN), AbbVie (ABBV), Eli Lilly and Company (LLY), and Pfizer (PFE).

Vertex Pharmaceuticals vs. Its Competitors

Amazon.com (NASDAQ:AMZN) and Vertex Pharmaceuticals (NASDAQ:VRTX) are related large-cap companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, dividends, institutional ownership, media sentiment, analyst recommendations and earnings.

Amazon.com presently has a consensus target price of $245.60, indicating a potential upside of 10.07%. Vertex Pharmaceuticals has a consensus target price of $511.62, indicating a potential upside of 12.53%. Given Vertex Pharmaceuticals' higher possible upside, analysts clearly believe Vertex Pharmaceuticals is more favorable than Amazon.com.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Amazon.com
0 Sell rating(s)
2 Hold rating(s)
45 Buy rating(s)
1 Strong Buy rating(s)
2.98
Vertex Pharmaceuticals
0 Sell rating(s)
14 Hold rating(s)
13 Buy rating(s)
1 Strong Buy rating(s)
2.54

72.2% of Amazon.com shares are held by institutional investors. Comparatively, 91.0% of Vertex Pharmaceuticals shares are held by institutional investors. 9.7% of Amazon.com shares are held by company insiders. Comparatively, 0.2% of Vertex Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Amazon.com had 224 more articles in the media than Vertex Pharmaceuticals. MarketBeat recorded 270 mentions for Amazon.com and 46 mentions for Vertex Pharmaceuticals. Vertex Pharmaceuticals' average media sentiment score of 1.11 beat Amazon.com's score of 0.86 indicating that Vertex Pharmaceuticals is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Amazon.com
161 Very Positive mention(s)
36 Positive mention(s)
48 Neutral mention(s)
16 Negative mention(s)
3 Very Negative mention(s)
Positive
Vertex Pharmaceuticals
34 Very Positive mention(s)
1 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Amazon.com has a beta of 1.33, indicating that its stock price is 33% more volatile than the S&P 500. Comparatively, Vertex Pharmaceuticals has a beta of 0.41, indicating that its stock price is 59% less volatile than the S&P 500.

Amazon.com has higher revenue and earnings than Vertex Pharmaceuticals. Vertex Pharmaceuticals is trading at a lower price-to-earnings ratio than Amazon.com, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Amazon.com$637.96B3.71$59.25B$6.1436.34
Vertex Pharmaceuticals$11.02B10.59-$535.60M-$3.92-115.98

Amazon.com has a net margin of 10.14% compared to Vertex Pharmaceuticals' net margin of -8.91%. Amazon.com's return on equity of 24.14% beat Vertex Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Amazon.com10.14% 24.14% 10.90%
Vertex Pharmaceuticals -8.91%-3.36%-2.42%

Summary

Amazon.com beats Vertex Pharmaceuticals on 12 of the 16 factors compared between the two stocks.

Get Vertex Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for VRTX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VRTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VRTX vs. The Competition

MetricVertex PharmaceuticalsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$116.75B$2.89B$5.49B$9.01B
Dividend YieldN/A2.43%5.38%4.09%
P/E Ratio-115.9821.5627.4220.26
Price / Sales10.59245.52407.97121.21
Price / CashN/A41.9536.6357.47
Price / Book7.137.518.085.67
Net Income-$535.60M-$55.05M$3.16B$248.47M
7 Day Performance3.02%4.59%2.81%3.29%
1 Month Performance1.97%4.86%3.68%5.19%
1 Year Performance-3.33%5.82%35.29%21.35%

Vertex Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VRTX
Vertex Pharmaceuticals
4.7279 of 5 stars
$454.64
-0.5%
$511.62
+12.5%
-3.3%$116.75B$11.02B-115.986,100Positive News
AMZN
Amazon.com
4.6198 of 5 stars
$219.65
-1.6%
$245.81
+11.9%
+12.9%$2.33T$637.96B35.771,556,000Trending News
Analyst Forecast
Insider Trade
AXSM
Axsome Therapeutics
4.7166 of 5 stars
$104.34
+0.9%
$172.33
+65.2%
+31.3%$5.14B$385.69M-18.08380Trending News
Analyst Forecast
Analyst Revision
CRSP
CRISPR Therapeutics
3.0472 of 5 stars
$48.54
+2.2%
$71.75
+47.8%
-3.2%$4.19B$35M-10.74473
GOOG
Alphabet
4.865 of 5 stars
$177.27
-0.6%
$206.38
+16.4%
-3.8%$2.15T$359.71B19.76190,200Trending News
Insider Trade
ISRG
Intuitive Surgical
4.344 of 5 stars
$543.38
+1.8%
$588.95
+8.4%
+25.1%$194.76B$8.35B79.6715,638Positive News
MRNA
Moderna
4.391 of 5 stars
$27.63
+1.7%
$46.61
+68.7%
-73.7%$10.69B$3.24B-3.165,800Options Volume
RGEN
Repligen
4.8194 of 5 stars
$124.24
+0.6%
$172.83
+39.1%
+5.5%$6.98B$634.44M-276.091,778Positive News
ABBV
AbbVie
4.9048 of 5 stars
$185.52
+1.8%
$211.29
+13.9%
+15.7%$327.70B$56.33B78.9555,000Trending News
Analyst Revision
LLY
Eli Lilly and Company
4.988 of 5 stars
$776.15
+0.1%
$1,011.61
+30.3%
-13.2%$735.59B$45.04B63.1547,000Positive News
PFE
Pfizer
4.976 of 5 stars
$24.23
+0.2%
$29.17
+20.4%
-8.0%$137.76B$63.63B17.5681,000Trending News

Related Companies and Tools


This page (NASDAQ:VRTX) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners